Title | The Secretion of miR-200s by a PKCζ/ADAR2 Signaling Axis Promotes Liver Metastasis in Colorectal Cancer. |
Publication Type | Journal Article |
Year of Publication | 2018 |
Authors | Shelton PM, Duran A, Nakanishi Y, Reina-Campos M, Kasashima H, Llado V, Ma L, Campos A, García-Olmo D, García-Arranz M, Garcia-Olmo DC, Olmedillas-López S, Caceres JF, Diaz-Meco MT, Moscat J |
Journal | Cell Rep |
Volume | 23 |
Issue | 4 |
Pagination | 1178-1191 |
Date Published | 2018 04 24 |
ISSN | 2211-1247 |
Keywords | Adenosine Deaminase, Animals, Cell-Derived Microparticles, Circulating MicroRNA, Colorectal Neoplasms, Liver Neoplasms, Mice, Mice, Knockout, MicroRNAs, Neoplasm Metastasis, Neoplasm Proteins, Protein Kinase C, RNA, Neoplasm, RNA-Binding Proteins |
Abstract | Most colorectal cancer (CRC)-related deaths are due to liver metastases. PKCζ is a tumor suppressor in CRC with reduced expression in metastasis. Given the importance of microRNAs (miRNAs) in regulating cellular plasticity, we performed an unbiased screening and identified the miR-200 family as the most relevant miRNAs downregulated by PKCζ deficiency. The regulation of the intracellular levels of miR-200 by PKCζ is post-transcriptional and involves their secretion in extracellular vesicles. Here, we identified ADAR2 as a direct substrate of PKCζ in CRC cells. Phosphorylation of ADAR2 regulates its editing activity, which is required to maintain miR-200 steady-state levels, suggesting that the PKCζ/ADAR2 axis regulates miR-200 secretion through RNA editing. Loss of this axis results in epithelial-to-mesenchymal transition (EMT) and increased liver metastases, which can be inhibited in vivo by blocking miR-200 release. Therefore, the PKCζ/ADAR2 axis is a critical regulator of CRC metastases through modulation of miR-200 levels. |
DOI | 10.1016/j.celrep.2018.03.118 |
Alternate Journal | Cell Rep |
PubMed ID | 29694894 |
PubMed Central ID | PMC5958623 |
Grant List | R01 DK108743 / DK / NIDDK NIH HHS / United States MC_PC_U127584479 / MRC_ / Medical Research Council / United Kingdom R01 CA172025 / CA / NCI NIH HHS / United States P30 CA030199 / CA / NCI NIH HHS / United States MC_UU_00007/7 / MRC_ / Medical Research Council / United Kingdom R01 CA207177 / CA / NCI NIH HHS / United States R01 CA192642 / CA / NCI NIH HHS / United States R01 CA218254 / CA / NCI NIH HHS / United States |
Related Faculty:
Jorge Moscat, Ph.D. Maria Diaz-Meco Conde, Ph.D.